Evaluation of multiple transcriptomic gene risk signatures in male breast cancer

HIGHLIGHTS

• who: Stefan Aebi and colleagues from the Patients and samples The retrospective cohort study of the EORTC/TBCRC/BIG/NABCG International Male Breast Cancer Program enrolled male patients with histologically proven BCa, diagnosed between , and, across multiple participating institutions Ethics approval was provided by the University of Toronto (#30035), a waiver of consent was approved since patient contact was not feasible due to death or loss to follow-up and the research involved no risk to patients whose identify was coded and confidentially protected. Patients with all disease stages (early, locally advanced, and metastatic) were included, irrespective . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.